ProPhase Labs Future Growth
Future criteria checks 5/6
ProPhase Labs is forecast to grow earnings and revenue by 77.4% and 86.3% per annum respectively while EPS is expected to grow by 44.4% per annum.
Key information
77.4%
Earnings growth rate
44.4%
EPS growth rate
Pharmaceuticals earnings growth | 19.8% |
Revenue growth rate | 86.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 27 Aug 2024 |
Recent future growth updates
Recent updates
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding
Nov 09It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks
Nov 09Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower
Jul 03Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?
Mar 04ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry
Jan 09ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate
Sep 21Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt
Aug 11We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease
Apr 07ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly
Jan 24ProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth Potential
Oct 13ProPhase Labs Q2 2022 Earnings Preview
Aug 10We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt
Jul 26ProPhase Labs to license two investigational cancer compounds from Global BioLife
Jul 21ProPhase Labs: A Stellar Quarter And Another Special Dividend
May 16Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 95 | 6 | N/A | N/A | 1 |
12/31/2025 | 50 | -16 | N/A | N/A | 1 |
12/31/2024 | 15 | -24 | N/A | N/A | 1 |
9/30/2024 | 13 | -28 | -17 | -14 | N/A |
6/30/2024 | 18 | -26 | -18 | -15 | N/A |
3/31/2024 | 29 | -24 | -21 | -17 | N/A |
12/31/2023 | 44 | -17 | -15 | -11 | N/A |
9/30/2023 | 63 | -10 | -14 | -10 | N/A |
6/30/2023 | 79 | -4 | -6 | -3 | N/A |
3/31/2023 | 94 | 7 | 5 | 9 | N/A |
12/31/2022 | 123 | 18 | 25 | 29 | N/A |
9/30/2022 | 146 | 31 | 21 | 23 | N/A |
6/30/2022 | 131 | 27 | 13 | 15 | N/A |
3/31/2022 | 111 | 18 | 13 | 15 | N/A |
12/31/2021 | 79 | 6 | -18 | -14 | N/A |
9/30/2021 | 39 | -5 | -21 | -16 | N/A |
6/30/2021 | 33 | -2 | -16 | -11 | N/A |
3/31/2021 | 28 | 0 | -16 | -11 | N/A |
12/31/2020 | 15 | -2 | -4 | -3 | N/A |
9/30/2020 | 12 | -2 | 3 | 4 | N/A |
6/30/2020 | 11 | -2 | 3 | 3 | N/A |
3/31/2020 | 9 | -3 | -2 | -2 | N/A |
12/31/2019 | 10 | -3 | -1 | -1 | N/A |
9/30/2019 | 11 | -3 | -1 | -1 | N/A |
6/30/2019 | 11 | -4 | -2 | -2 | N/A |
3/31/2019 | 12 | -3 | -1 | -1 | N/A |
12/31/2018 | 13 | -2 | -2 | -2 | N/A |
9/30/2018 | 13 | -1 | -3 | -3 | N/A |
6/30/2018 | 14 | -1 | N/A | -2 | N/A |
3/31/2018 | 13 | -1 | N/A | -6 | N/A |
12/31/2017 | 10 | -2 | N/A | -3 | N/A |
9/30/2017 | 6 | -3 | N/A | -1 | N/A |
6/30/2017 | 5 | -3 | N/A | -1 | N/A |
3/31/2017 | 4 | -3 | N/A | 2 | N/A |
12/31/2016 | 4 | -4 | N/A | 0 | N/A |
9/30/2016 | -6 | -3 | N/A | -2 | N/A |
6/30/2016 | -3 | -2 | N/A | -4 | N/A |
3/31/2016 | -2 | -2 | N/A | -5 | N/A |
12/31/2015 | 3 | -2 | N/A | -3 | N/A |
9/30/2015 | 21 | -3 | N/A | -4 | N/A |
6/30/2015 | 22 | -7 | N/A | -3 | N/A |
3/31/2015 | 22 | -8 | N/A | -4 | N/A |
12/31/2014 | 22 | -8 | N/A | -3 | N/A |
9/30/2014 | 23 | -7 | N/A | -1 | N/A |
6/30/2014 | 24 | -2 | N/A | -1 | N/A |
3/31/2014 | 24 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PRPH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: PRPH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PRPH is expected to become profitable in the next 3 years.
Revenue vs Market: PRPH's revenue (86.3% per year) is forecast to grow faster than the US market (9.2% per year).
High Growth Revenue: PRPH's revenue (86.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PRPH's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/31 09:05 |
End of Day Share Price | 2024/12/31 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ProPhase Labs, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hunter Diamond | Diamond Equity Research LLC |
Ashok Kumar | ThinkEquity LLC |